Here are relevant reports on : drug-discovery-and-development-market
-
Antigen & Antibodies Market by Product (Antigens, ABs), Technique (ELISA, CLIA, IHS, IFA), Application (Diagnosis, Drug Discovery, Research), Healthcare Provider Facilities (ASCs & Clinics, Labs, Biotech& Pharma Companies) - Global Forecast to 2027
The global Antigen and Antibodies Market is expected to reach USD xx billion by 2027 from USD xx billion in 2022, at a CAGR of xx%. The growth in this market is driven by the advancing proteomics and genomics research, massive use of antigen and antibodies in the vaccine development, drug discovery, disease study and diagnosis.
- Published: June 2026
- Price: $ 4950
- TOC Available:
-
Gene Editing Market by Product (Kits, Reagents, Libraries, Software), Services (gRNA Synthesis & Vector Construction), Technique (Knock-Out, Knock-In), Technology (CRISPR, ZFN, TALEN), Application (Genome Editing, Drug Discovery) - Global Forecast to 2029
The global gene editing market, valued at US$4.44 billion in 2023, stood at US$4.66 billion in 2024 and is projected to advance at a resilient CAGR of 10.2% from 2024 to 2029, culminating in a forecasted valuation of US$7.59 billion by the end of the period. The main factors driving the expansion of this market are the demand for personalized medicine and favorable government funding for gene editing projects.
- Published: November 2024
- Price: $ 4950
- TOC Available:
-
Digital Twins in Healthcare Market By Component (Software, Services), Application (Personalized Medicine, Drug Discovery, Medical Education, Workflow Optimization), End User (Providers, Research & Academia, Payers), and Region - Global Forecast to 2031
The global digital twins in healthcare market is projected to reach USD 101.19 billion by 2031, growing at a CAGR of 68.4% during the forecast period (2026–2031). The report covers key segments, regional analysis, and competitive landscape across the market ecosystem.
- Published: April 2026
- Price: $ 4950
- TOC Available:
-
NGS Sample Preparation Market by Product (Reagents & Consumables, Workstations), Workflow (Library Prep, Target Enrichment), Sample Type (DNA), Application (Diagnostics, Drug Discovery), Method (Microfluidic, Automated), End User & Region - Global Forecast to 2028
The global NGS sample preparation market in terms of revenue was estimated to be worth $1.9 billion in 2022 and is poised to reach $4.0 billion by 2028, growing at a CAGR of 13.4% from 2022 to 2028. The market for NGS sample preparation is highly consolidated, with key players strategizing to capture the market. Prominent players in the NGS sample preparation market are Illumina, Inc. (US), Thermo Fisher Scientific Inc. (US), PerkinElmer Inc. (US), F. Hoffmann-La Roche Ltd. (Switzerland), Agilent Technologies, Inc. (US), Danaher (US), Becton, Dickinson and Company (US), Merck KGAA (Germany), QIAGEN (Germany), Bio-Rad Laboratories, Inc. (US), Promega Corporation (US), Eurofins Scientific (Luxembourg), BGI (China), 10x Genomics (US), Sysmex Corporation (US), Psomagen (US), Zymo Research Corporation (US), Takara Bio Inc. (Japan), Novogene Co., Ltd. (China), New England Biolabs (US), Tecan Trading AG (US), Oxford Nanopore Technologies PLC (UK), PacBio (US), Medgenome (US), and Swift Biosciences Inc. (US).
- Published: March 2023
- Price: $ 4950
- TOC Available:
-
Metagenomic Sequencing Market by Product & Services (Reagent, Consumables, Instrument), Workflow (Sample Preparation, Sequencing), Technology (16S rRNA, Shotgun, Whole-genome), Application (Drug Discovery, Diagnostic, Industrial) - Global Forecast to 2028
The global metagenomic sequencing market, valued at US$1.8 billion in 2022, stood at US$2.0 billion in 2023 and is projected to advance at a resilient CAGR of 17.5% from 2023 to 2028, culminating in a forecasted valuation of US$4.5billion by the end of the period. NGS platforms have undergone continuous technological innovations over the last several years.
- Published: July 2023
- Price: $ 4950
- TOC Available:
-
Proteomics Services Market by Service Type (Core Proteomics, Bioinformatics), Application (Clinical, Drug Discovery), End User (Biopharmaceuticals, Hospitals) - Global Forecast to 2030
The global proteomics services market, valued at US$8.06 billion in 2024, stood at US$8.77 billion in 2025 and is projected to advance at a resilient CAGR of 13.4% from 2025 to 2030, culminating in a forecasted valuation of US$16.46 billion by the end of the period. This growth is driven by advances in multiplexing, automation, and bioinformatics, which enable deeper analysis of protein interactions, biomarker discovery, and assay development, improving insights into therapeutic responses, diagnostics, and functional applications.
- Published: May 2026
- Price: $ 4950
- TOC Available:
-
North America Proteomics Market by Instrumentation (Mass Spectrometry, HPLC, Electrophoresis, Protein Microarray), Reagent (Immunoassay), Service (Purification, Bioinformatics), Software, Application (Clinical, Drug Discovery)- Forecast to 2030
The North America Proteomics market, valued at USD13.06 billion in 2024, stood at USD14.11 billion in 2025 and is projected to advance at a resilient CAGR of 12.7% from 2025 to 2030, culminating in a forecasted valuation of USD25.62 billion by the end of the period. The growing use of proteomics in precision oncology, cardiology, and other complex diseases, together with strong momentum in clinical trials, is driving demand for high-throughput, reliable platforms in hospitals and research centers.
- Published: May 2026
- Price: $ 4950
- TOC Available:
-
Asia Pacific Next-generation Sequencing Market by Product Type (Consumables, Platforms, Bioinformatics), Technology (SBS, Nanopore), Workflow (Sequencing, Data Analysis), Services, Application (Drug Discovery, Diagnostic, Agriculture) - Forecast to 2030
The Asia Pacific Next-generation Sequencing market, valued at US$3.11 billion in 2024, stood at US$3.40 billion in 2025 and is projected to advance at a resilient CAGR of 16.7% from 2025 to 2030, culminating in a forecasted valuation of US$7.38 billion by the end of the period. Market growth is supported by substantial public and private investment in genomics, including national genome and precision medicine initiatives in China, Japan, India, South Korea, Singapore, and Australia, alongside ongoing advances that are lowering sequencing costs and improving throughput and data analytics.
- Published: May 2026
- Price: $ 4950
- TOC Available:
-
Asia-Pacific Microscopy Market by Product [Optical Microscope: Stereo, Digital; Electron microscope: SEM, TEM, AFM, STM], Application (Pharma Mfg, Pathology, Drug Discovery, Toxicology), End User (Pharma-biopharma, Academia, Semiconductor) — Forecast to 2031
The Asia-Pacific microscopy market is projected to reach USD 2.56 billion by 2031, growing at a CAGR of 6.5% during the forecast period (2026–2031). The report covers key segments, regional analysis, and competitive landscape across the market ecosystem.
- Published: May 2026
- Price: $ 4950
- TOC Available:
-
China Next-Generation Sequencing Market by Product Type (Consumables, Platforms, Bioinformatics), Technology (SBS, Nanopore), Workflow (Sequencing, Platforms, Bioinformatics), Application (Drug Discovery, Diagnostic, Agriculture) - Forecast to 2031
The China Next-Generation Sequencing market, valued at USD 1.23 billion in 2025, stood at USD 1.35 billion in 2026 and is projected to advance at a resilient CAGR of 16.0% from 2026 to 2031, culminating in a forecasted valuation of USD 2.84 billion by the end of the period. Next-generation sequencing refers to advanced DNA and RNA sequencing technologies that enable rapid, high-throughput analysis of genetic material.
- Published: May 2026
- Price: $ 4950
- TOC Available:
Records 31 to 40 of 50
